Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1996
Flow cytometric assay of modulation of P-glycoprotein function in whole blood by the multidrug resistance inhibitor GG918S M Witherspoon, D L Emerson, B M Kerr, et al.
Life Sciences|May 4, 1987
Diet-hormone interactions: protein/carbohydrate ratio alters reciprocally the plasma levels of testosterone and cortisol and their respective binding globulins in manK E Anderson, W Rosner, M S Khan, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1982
The development and application of a radioimmunoassay for dihydrodigoxin, a digoxin metaboliteV P Butler, D Tse-Eng, J Lindenbraum, et al.
Anti-Cancer Drugs|November 26, 1999
Clinical pharmacokinetics of doxorubicin in combination with GF120918, a potent inhibitor of MDR1 P-glycoproteinA Sparreboom, A S Planting, R C Jewell, et al.
Cancer Chemotherapy and Pharmacology|November 27, 2004
A phase I and pharmacologic study of the MDR converter GF120918 in combination with doxorubicin in patients with advanced solid tumorsA S T Planting, P Sonneveld, A van der Gaast, et al.
Investigational New Drugs|May 11, 2002
Population pharmacokinetic and dynamic analysis of the topoisomerase I inhibitor lurtotecan in phase II studiesJ H M Schellens, B Heinrich, M Lehnert, et al.
Pageof 2